The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study-Reference-Cited by-同舟云学术

The impact of previous or concomitant IFN therapy on deferiprone-induced agranulocytosis and neutropenia: a retrospective study

Published:2010-10-14 Issue:6 Volume:9 Page:875-881
ISSN:1474-0338
Container-title:Expert Opinion on Drug Safety
language:en
Short-container-title:Expert Opinion on Drug Safety

Author:

Ricchi Paolo,Ammirabile Massimiliano,Costantini Silvia,Cinque Patrizia,Lanza Alfonso Galeota,Spasiano Anna,Di Matola Tiziana,Di Costanzo Giovanni,Pagano Leonilde,Prossomariti Luciano

Publisher

Informa Healthcare

Subject

Pharmacology (medical),General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1517/14740338.2010.510831

Reference20 articles.

1. Safety and effectiveness of long-term therapy with the oral iron chelator deferiprone

2. The safety and effectiveness of deferiprone in a large-scale, 3-year study in Italian patients

3. Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

4. Effectiveness and safety of combined iron-chelation therapy with deferoxamine and deferiprone

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatocellular carcinoma in patients with thalassemia in the post-DAA era: not a disappearing entity;Annals of Hematology;2021-04-13

Thalassemia and hepatocellular carcinoma: links and risks

;Journal of Blood Medicine;2019-09

3. Rechallenging to Hydroxycarbamide Post Thalidomide Treatment and Response in a Non Transfusion-Dependent Patient, is it Possible?;Indian Journal of Hematology and Blood Transfusion;2019-02-11

4. Tetrahydrocurcumin in combination with deferiprone attenuates hypertension, vascular dysfunction, baroreflex dysfunction, and oxidative stress in iron-overloaded mice;Vascular Pharmacology;2016-12

5. Deferiprone‐induced agranulocytosis: 20 years of clinical observations;American Journal of Hematology;2016-08-04